01—Abstract
Summary
Summary of the 8-K filed February 17, 2023. Cited figures are marked; the original filing is the authoritative source.
Northrop Grumman Corporation (NOC) filed an 8-K on February 16, 2023, detailing compensation actions for its named executive officers and a board director's departure.
The Compensation Committee and Board approved the 2023 incentive plan goals, with a significant weighting on financial metrics such as cash flow from operations, segment operating income growth, and adjusted operating margin, alongside non-financial metrics like People, Environment, and Customer. Additionally, Restricted Performance Stock Rights (RPSR) for the 2023-2025 performance period were awarded, focusing on cumulative free cash flow, return on invested capital, and relative total shareholder return. Restricted Stock Rights (RSR) were also approved.
The company continues its practice of not awarding stock options. These compensation adjustments align executive incentives with key financial and strategic objectives.
02—Key points
Key Highlights
- Northrop Grumman's Compensation Committee and Board approved the 2023 Annual Incentive Plan (ICP) and Incentive Compensation Plan (ICP) goals.
- Financial metrics for the 2023 ICP include cash flow from operations (35%), segment operating income growth (35%), and adjusted operating margin (20%).
- Non-financial metrics for the 2023 ICP comprise People (DE&I, employee experience), Environment (sustainability), and Customer (quality, satisfaction), weighted at 10%.
- Restricted Performance Stock Rights (RPSR) for 2023-2025 performance period were awarded, with metrics: cumulative free cash flow (1/3), return on invested capital (1/3), and relative total shareholder return (1/3).
- Restricted Stock Rights (RSR) were approved to vest on February 17, 2026.
- The company has maintained its policy of not awarding stock options to named executive officers.
- Director Karl J. Krapek will not seek re-election at the 2023 Annual Meeting of Shareholders and will retire from the Board.
03—Questions
Frequently Asked Questions
What are the key financial metrics driving executive compensation for 2023 under the Incentive Compensation Plan (ICP)?
The primary financial metrics for the 2023 ICP are cash flow from operations before discretionary pension funding (35%), segment operating income growth (35%), and adjusted operating margin rate (20%). These represent a substantial portion of the incentive opportunity.
What are the performance measures for the Restricted Performance Stock Rights (RPSR) awarded for the 2023-2025 period?
The RPSR awards for the 2023-2025 performance period will be measured against cumulative free cash flow (1/3 weighting), return on invested capital (1/3 weighting), and relative total shareholder return (1/3 weighting). These metrics are designed to align executive interests with long-term shareholder value creation.
Are there any significant changes to the compensation structure compared to 2022?
The filing states that other than as described, there are no material changes from 2022 in the terms of the 2023 RPSR and RSR awards for named executive officers. The company also continues its practice of not awarding stock options.
Is there any change in the Board of Directors mentioned in this filing?
Yes, Director Karl J. Krapek has notified the Board of his decision not to seek re-election at the 2023 Annual Meeting of Shareholders. He will retire from the Board at that meeting.
04—Continue